Fidelity Disruptive Medicine ETF (FMED)
NASDAQ: FMED · Real-Time Price · USD
27.79
+0.07 (0.25%)
Jan 9, 2026, 4:00 PM EST - Market closed
FMED Holdings Information
FMED is an equity ETF with a total of 75 individual holdings. The top holdings are Fidelity Securities Lending Cash Central Fund stock at 4.63%, Boston Scientific at 4.54%, UCB SA at 3.79%, argenx SE at 3.77%, and Alnylam Pharmaceuticals at 3.76%.
Total Holdings
75
Top 10 Percentage
36.49%
Asset Class
Equity
ETF Category
Health
Assets
65.24M
PE Ratio
43.97
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | n/a | Fidelity Securities Lending Cash Central Fund | 4.63% |
| 2 | BSX | Boston Scientific Corporation | 4.54% |
| 3 | EBR: UCB | UCB SA | 3.79% |
| 4 | ARGX | argenx SE | 3.77% |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 3.76% |
| 6 | DHR | Danaher Corporation | 3.57% |
| 7 | COGT | Cogent Biosciences, Inc. | 3.46% |
| 8 | ISRG | Intuitive Surgical, Inc. | 3.09% |
| 9 | VEEV | Veeva Systems Inc. | 2.97% |
| 10 | PEN | Penumbra, Inc. | 2.92% |
| 11 | PODD | Insulet Corporation | 2.90% |
| 12 | WAY | Waystar Holding Corp. | 2.43% |
| 13 | LFST | LifeStance Health Group, Inc. | 2.37% |
| 14 | EW | Edwards Lifesciences Corporation | 2.29% |
| 15 | EPA: DIM | Sartorius Stedim Biotech S.A. | 2.20% |
| 16 | n/a | Fidelity Cash Central Fund | 1.99% |
| 17 | TMO | Thermo Fisher Scientific Inc. | 1.92% |
| 18 | MASI | Masimo Corporation | 1.90% |
| 19 | LLY | Eli Lilly and Company | 1.73% |
| 20 | SYK | Stryker Corporation | 1.67% |
| 21 | LEGN | Legend Biotech Corporation | 1.61% |
| 22 | UNH | UnitedHealth Group Incorporated | 1.60% |
| 23 | PCVX | Vaxcyte, Inc. | 1.58% |
| 24 | CRNX | Crinetics Pharmaceuticals, Inc. | 1.57% |
| 25 | NTRA | Natera, Inc. | 1.55% |
As of Jan 8, 2026